Westpac Banking Corp Bristol Myers Squibb CO Transaction History

Westpac Banking Corp

$1.49 Trillion
Q3 2024

A detailed history of Westpac Banking Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Westpac Banking Corp holds 38,333 shares of BMY stock, worth $2.21 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

38,333

Previous 22,700 68.87%

Holding current value

$2.21 Million

Previous $943 Million 110.38%

% of portfolio

0.13%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$39.66 - $51.75 $620,004 - $809,007	15,633 Added 68.87%	38,333 $1.98 Billion
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $911,984 - $1.2 Million	22,658 Added 53947.62%	22,700 $943 Million
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $4.88 Million - $6.43 Million	-121,338 Reduced 99.97%	42 $943 Million
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $539,775 - $612,000	11,250 Added 10.22%	121,380 $6.58 Billion
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $244,387 - $291,621	-5,041 Reduced 4.38%	110,130 $5.65 Billion
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $13,662 - $15,276	236 Added 0.21%	115,171 $6.68 Billion
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $20.3 Million - $22.5 Million	-318,663 Reduced 73.49%	114,935 $7.35 Billion
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $544,933 - $618,077	8,293 Added 1.95%	433,598 $30.1 Billion
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $2.18 Million - $2.58 Million	31,806 Added 8.08%	425,305 $30.6 Billion
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $1,999 - $1.18 Million	15,379 Added 4.07%	393,499 $28 Billion
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $9.25 Million - $10.2 Million	127,325 Added 50.77%	378,120 $29.1 Billion
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $3.32 Million - $3.98 Million	54,004 Added 27.44%	250,795 $18.3 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $930,963 - $1.09 Million	17,359 Added 9.67%	196,791 $12.3 Billion
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $745,837 - $873,652	-12,605 Reduced 6.56%	179,432 $10.6 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $1.37 Million - $1.5 Million	-22,188 Reduced 10.36%	192,037 $12.8 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $723,651 - $813,894	12,195 Added 6.04%	214,225 $13.5 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $2.86 Million - $3.24 Million	-49,466 Reduced 19.67%	202,030 $12.5 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $1.4 Million - $1.55 Million	-24,380 Reduced 8.84%	251,496 $15.2 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $2.35 Million - $2.74 Million	-42,816 Reduced 13.43%	275,876 $16.2 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $2.92 Million - $4.24 Million	-62,830 Reduced 16.47%	318,692 $17.8 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $4 Million - $5.21 Million	81,219 Added 27.05%	381,522 $24.5 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $2.81 Million - $3.34 Million	-65,806 Reduced 17.97%	300,303 $15.2 Million
Q2 2019 Aug 01, 2019	BUY	$44.62 - $49.34 $476,720 - $527,148	10,684 Added 3.01%	366,109 $0
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $2.06 Million - $2.45 Million	-45,548 Reduced 11.36%	355,425 $0
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $3.02 Million - $3.92 Million	61,963 Added 18.28%	400,973 $20.8 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $4.78 Million - $5.39 Million	86,587 Added 34.3%	339,010 $0
Q2 2018 Jul 18, 2018	BUY	$50.53 - $62.98 $326,828 - $407,354	6,468 Added 2.63%	252,423 $0
Q1 2018 May 01, 2018	BUY	$59.92 - $68.98 $3.7 Million - $4.25 Million	61,680 Added 33.47%	245,955 $0
Q4 2017 Jan 18, 2018	SELL	$59.94 - $65.35 $1.56 Million - $1.7 Million	-26,000 Reduced 12.36%	184,275 $0
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $11.6 Million - $13.4 Million	210,275	210,275 $0

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Account

Westpac Banking Corp Bristol Myers Squibb CO Transaction History